Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

S Le Gouill; Nicolaus Kröger; N Dhedin; A Nagler; K Bouabdallah; I Yakoub-Agha; T Kanouni; C E Bulabois; O Tournilhac; A Buzyn; B Rio; M P Moles; A Shimoni; Ulrike Bacher; Sunday Ocheni; N Milpied; J L Harousseau; P Moreau; C Leux; M Mohty

doi:10.1093/annonc/mds054

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

S Le Gouill
Nicolaus Kröger
N Dhedin
A Nagler
K Bouabdallah
I Yakoub-Agha
T Kanouni
C E Bulabois
O Tournilhac
A Buzyn
B Rio
M P Moles
A Shimoni
Ulrike Bacher
Sunday Ocheni
N Milpied
J L Harousseau
P Moreau
C Leux
M Mohty

Beteiligte Einrichtungen

Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation

Abstract

Despite therapeutic approach that combines rituximab-containing chemotherapy, followed or not by autologous stem cell transplantation (auto-SCT), mantle cell lymphoma (MCL) patients experience relapses. Reduced-intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) at time of relapse may represent an attractive strategy.

Bibliografische Daten

Originalsprache	Englisch
Aufsatznummer	10
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mds054
Status	Veröffentlicht - 01.10.2012

pubmed	22440229